Advertisement

Topics

Veracyte Announces Launch of New Afirma Xpression Atlas at 2018 AACE Congress

15:19 EDT 16 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Veracyte, Inc. (Nasdaq: VCYT) today announced the launch of the new Afirma Xpression Atlas, an RNA sequencing-based test that provides extensive genomic information to aid in surgery and treatment decisions for patients w...

Other Sources for this Article

Veracyte, Inc.
Tracy Morris, 650-380-4413
tracy.morris@veracyte.com
or
Investors:
Keith Kennedy, 650-243-6357
Chief Financial Officer
keith@veracyte.com

NEXT ARTICLE

More From BioPortfolio on "Veracyte Announces Launch of New Afirma Xpression Atlas at 2018 AACE Congress"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...